Wikipedia -WSS

Wikipedia

author：explore 2025-10-02 03:47:08 - browse：71

Julia Rendleman/Getty Images for Eventive Marketing

Health insurer Cigna is paying more than $172 million to settle allegations that it committed fraud by knowingly submitting inaccurate diagnoses of its Medicare Advantage members, the company and Department of Justice announced Saturday.

The settlement stems from a wide-ranging government investigation into the coding practices of Medicare Advantage insurers, as well as a specific whistleblower lawsuit against Cigna that the DOJ joined last year.

That lawsuit alleged Cigna’s home visit program “regularly generated false and invalid diagnosis codes for certain serious, complex conditions that cannot be reliably diagnosed in a home setting and without extensive diagnostic testing or imaging,” the DOJ said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： A common UTI test for kids haunts adults as a traumatic 'nightmare'

WSS

NIH study of ME/CFS points to clear biological hallmarks

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

What to make of Biden’s latest efforts on cancer research

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

New documents shed light on MD Anderson Cancer Institute feud

Pig kidney works a record two months in donated body

explore

Wikipedia

entertainment

How one medical school became remarkably diverse

Alabama hospital puts IVF treatments on hold

The high cost of giving birth even with insurance

Medicare inequities exacerbate Puerto Rico’s health disparities

Hollywood unions extend contract negotiations for actors

NIH study of ME/CFS points to clear biological hallmarks

Sports medicine is finally prioritizing gender equality

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

Medical leaders decry Supreme Court decision on affirmative action

A common UTI test for kids haunts adults as a traumatic 'nightmare'

hotspot

In utero gene editing: an explainer

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

White House touts steps to stem shortages of cancer treatments

Will the IRA bring competition to the biologics market?

Long Covid needs a new name — and a new frame

How to make the FDA’s new prescription one

hotspot

knowledge

entertainment

leisure time